Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Svetomir N Markovic

Showing results (1-10 of 257) with videos related to

Pageof 26
Sort By:
Expert Review of Anticancer Therapy|April 12, 2008
Emerging therapies for melanomaRajini Katipamula, Svetomir N Markovic
Current Opinion in Molecular Therapeutics|March 3, 2007
Tumor immunotherapy in melanoma: on the dawn of a new era?Ryan Wilcox, Svetomir N Markovic
Trends in Immunology|August 12, 2023
Melanoma-derived mediators can foster the premetastatic niche: crossroad to lymphatic metastasisShankar Suman, Svetomir N Markovic
Expert Review of Anticancer Therapy|May 19, 2012
Molecular targets in melanoma: time for 'ethnic personalization'Shane Y Morita, Svetomir N Markovic
World Journal of Clinical Oncology|May 24, 2011
Autograft mediated adoptive immunotherapy of cancer in the context of autologous stem cell transplantationLuis F Porrata, Svetomir N Markovic
Current Oncology Reports|September 6, 2013
Inhibition of angiogenesis for the treatment of metastatic melanomaAaron S Mansfield, Svetomir N Markovic
Future Oncology (London, England)|May 20, 2009
Novel therapeutics for the treatment of metastatic melanomaAaron S Mansfield, Svetomir N Markovic
Mayo Clinic Proceedings|April 9, 2002
Challenges in the development of effective peptide vaccines for cancerChantal Buteau, Svetomir N Markovic, Esteban Celis
Expert Review of Anticancer Therapy|November 5, 2015
Nab-paclitaxel in patients with metastatic melanomaRoberto A Leon-Ferre, Svetomir N Markovic
BMC Medicine|March 6, 2012
Therapy for metastatic melanoma: the past, present, and futureLaura Finn, Svetomir N Markovic, Richard W Joseph
Pageof 26

Showing results (1-10 of 257) with videos related to

Sort By:
Pageof 26
Expert Review of Anticancer Therapy|April 12, 2008
Emerging therapies for melanomaRajini Katipamula, Svetomir N Markovic
Current Opinion in Molecular Therapeutics|March 3, 2007
Tumor immunotherapy in melanoma: on the dawn of a new era?Ryan Wilcox, Svetomir N Markovic
Trends in Immunology|August 12, 2023
Melanoma-derived mediators can foster the premetastatic niche: crossroad to lymphatic metastasisShankar Suman, Svetomir N Markovic
Expert Review of Anticancer Therapy|May 19, 2012
Molecular targets in melanoma: time for 'ethnic personalization'Shane Y Morita, Svetomir N Markovic
World Journal of Clinical Oncology|May 24, 2011
Autograft mediated adoptive immunotherapy of cancer in the context of autologous stem cell transplantationLuis F Porrata, Svetomir N Markovic
Current Oncology Reports|September 6, 2013
Inhibition of angiogenesis for the treatment of metastatic melanomaAaron S Mansfield, Svetomir N Markovic
Future Oncology (London, England)|May 20, 2009
Novel therapeutics for the treatment of metastatic melanomaAaron S Mansfield, Svetomir N Markovic
Mayo Clinic Proceedings|April 9, 2002
Challenges in the development of effective peptide vaccines for cancerChantal Buteau, Svetomir N Markovic, Esteban Celis
Expert Review of Anticancer Therapy|November 5, 2015
Nab-paclitaxel in patients with metastatic melanomaRoberto A Leon-Ferre, Svetomir N Markovic
BMC Medicine|March 6, 2012
Therapy for metastatic melanoma: the past, present, and futureLaura Finn, Svetomir N Markovic, Richard W Joseph
Pageof 26